Diagnosis and management of early asthma in preschool-aged children.

Asthma is a common disease in young children and is associated with significant morbidity and an increasing prevalence over time. Early childhood wheezing and asthma are heterogeneous disorders; thus identifying phenotypes of asthma remains a goal to identify high-risk children who might benefit from specific therapies or secondary prevention interventions. The typical pattern of illness in preschool-aged children consists of short but recurrent exacerbations of cough and wheeze usually triggered by viral respiratory tract infections. Documenting reversible airflow obstruction on lung function, allergen sensitization, increased IgE levels, or blood eosinophilia is helpful in establishing a diagnosis of asthma in preschool-aged children, if present; however, the diagnosis is most often based on symptom patterns, presence of risk factors, and therapeutic responses. The preschool-aged asthmatic population tends to be characterized as exacerbation prone with relatively limited impairment, unlike older children and adolescents who have more impairment-dominant disease. However, management of persistent disease is based largely on expert opinion and extrapolation from studies in older children given the relative lack of data in this age group. Strategies used to manage intermittent disease include daily and intermittent controller therapy. Management strategies for persistent asthma include daily inhaled corticosteroids, daily leukotriene receptor antagonists, and combination therapies. Finally, regular monitoring of symptom control and medication side effects is important along with titrating controllers to the minimally effective dose.

[1]  W. Busse,et al.  Middleton's Allergy: Principles and Practice , 2013 .

[2]  T. van der Molen,et al.  Fluticasone or montelukast for preschool children with asthma-like symptoms: Randomized controlled trial. , 2008, Pulmonary pharmacology & therapeutics.

[3]  B. Nickerson,et al.  Lung function measurement in the assessment of childhood asthma: recent important developments , 2010, Current opinion in allergy and clinical immunology.

[4]  G. Shapiro,et al.  Efficacy and safety of budesonide inhalation suspension (Pulmicort Respules) in young children with inhaled steroid-dependent, persistent asthma. , 1998, The Journal of allergy and clinical immunology.

[5]  M. Welch,et al.  A multiple-dosing, placebo-controlled study of budesonide inhalation suspension given once or twice daily for treatment of persistent asthma in young children and infants. , 1999, Pediatrics.

[6]  J. Castro‐Rodriguez,et al.  The Asthma Predictive Index: a very useful tool for predicting asthma in young children. , 2010, The Journal of allergy and clinical immunology.

[7]  J. Warner Asthma in Infancy and Childhood , 2009 .

[8]  C. Sorkness,et al.  Growth of preschool children at high risk for asthma 2 years after discontinuation of fluticasone. , 2011, The Journal of allergy and clinical immunology.

[9]  B. Chipps Intermittent Inhaled Corticosteroids in Infants With Episodic Wheezing , 2007, Pediatrics.

[10]  H. Derkx,et al.  Gastroesophageal reflux in infants with wheezing. , 2000, Pediatric pulmonology.

[11]  S. Sekhsaria,et al.  Efficacy and Safety of Inhaled Corticosteroids in Combination with a Long‐Acting Beta2‐Agonist in Asthmatic Children Under Age 5 , 2004, The Journal of asthma : official journal of the Association for the Care of Asthma.

[12]  D. Allen Inhaled steroids for children: effects on growth, bone, and adrenal function. , 2005, Endocrinology and metabolism clinics of North America.

[13]  M. Sears,et al.  Attenuation of the September Epidemic of Asthma Exacerbations in Children: A Randomized, Controlled Trial of Montelukast Added to Usual Therapy , 2007, Pediatrics.

[14]  Vital signs: asthma prevalence, disease characteristics, and self-management education: United States, 2001--2009. , 2011, MMWR. Morbidity and mortality weekly report.

[15]  H. Bisgaard,et al.  Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach , 2008, European Respiratory Journal.

[16]  H. Bisgaard,et al.  The effect of inhaled fluticasone propionate in the treatment of young asthmatic children: a dose comparison study. , 1999, American journal of respiratory and critical care medicine.

[17]  J. Castro‐Rodriguez,et al.  Efficacy of Inhaled Corticosteroids in Infants and Preschoolers with Recurrent Wheezing and Asthma: A Systematic Review with Meta-Analysis. , 2009, ATS 2009.

[18]  J. Warner Wheezing Disorders in the Preschool Child: Pathogenesis and Management , 2004 .

[19]  Z. Zonis,et al.  Diagnostic evaluation of foreign body aspiration in children: a prospective study. , 2005, Journal of pediatric surgery.

[20]  N. Santanello,et al.  Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years. , 2001, Pediatrics.

[21]  T. Green,et al.  Montelukast Reduces Asthma Exacerbations in 2- to 5-Year-Old Children With Intermittent Asthma , 2006, Pediatrics.

[22]  Ayne,et al.  ASTHMA AND WHEEZING IN THE FIRST SIX YEARS OF LIFE , 1995 .

[23]  D. Postma,et al.  Comparison of childhood wheezing phenotypes in 2 birth cohorts: ALSPAC and PIAMA. , 2011, The Journal of allergy and clinical immunology.

[24]  M. Malice,et al.  Analysis of behavior-related adverse experiences in clinical trials of montelukast. , 2009, The Journal of allergy and clinical immunology.

[25]  R. Platt,et al.  Preemptive use of high-dose fluticasone for virus-induced wheezing in young children. , 2009, The New England journal of medicine.

[26]  R. Castile Novel Techniques for Assessing Infant and Pediatric Lung Function and Structure , 2004, The Pediatric infectious disease journal.

[27]  K. Carlsen,et al.  Severity of obstructive airways disease by age 2 years predicts asthma at 10 years of age , 2007, Thorax.

[28]  L. Bacharier,et al.  Phenotypic Expressions of Childhood Wheezing and Asthma: Implications for Therapy , 2011, The Journal of Pediatrics.

[29]  Stefano Guerra,et al.  Outcome of asthma and wheezing in the first 6 years of life: follow-up through adolescence. , 2005, American journal of respiratory and critical care medicine.

[30]  Peter D Sly,et al.  Global strategy for the diagnosis and management of asthma in children 5 years and younger , 2011, Pediatric pulmonology.

[31]  C. Sorkness,et al.  Atopic characteristics of children with recurrent wheezing at high risk for the development of childhood asthma. , 2004, The Journal of allergy and clinical immunology.

[32]  W. Freeman,et al.  Can we predict which wheezy infants will continue to wheeze? , 1999, American journal of respiratory and critical care medicine.

[33]  M. Newhouse,et al.  Factors that affect the efficacy of inhaled corticosteroids for infants and young children. , 2010, The Journal of allergy and clinical immunology.

[34]  E. Valovirta,et al.  Intermittent or daily montelukast versus placebo for episodic asthma in children. , 2011, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[35]  D. Sherrill,et al.  Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years , 1999, The Lancet.

[36]  A. Boner,et al.  Regular vs prn nebulized treatment in wheeze preschool children , 2009, Allergy.

[37]  S. Holgate,et al.  Characterization of wheezing phenotypes in the first 10 years of life , 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[38]  S. Szefler,et al.  Budesonide inhalation suspension: a nebulized corticosteroid for persistent asthma. , 2002, The Journal of allergy and clinical immunology.

[39]  J. Kemp,et al.  Once-daily budesonide inhalation suspension for the treatment of persistent asthma in infants and young children. , 1999, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[40]  S. Szefler,et al.  Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma. , 2007, The Journal of allergy and clinical immunology.

[41]  N. Santanello,et al.  Response to montelukast among subgroups of children aged 2 to 14 years with asthma. , 2003, The Journal of allergy and clinical immunology.

[42]  L. Bacharier Evaluation of the child with recurrent wheezing. , 2011, The Journal of allergy and clinical immunology.

[43]  J. Castro‐Rodriguez The Asthma Predictive Index: early diagnosis of asthma , 2011, Current opinion in allergy and clinical immunology.

[44]  L. Bacharier,et al.  Patient characteristics associated with improved outcomes with use of an inhaled corticosteroid in preschool children at risk for asthma. , 2009, The Journal of allergy and clinical immunology.

[45]  H. Bisgaard,et al.  Twelve-month safety and efficacy of inhaled fluticasone propionate in children aged 1 to 3 years with recurrent wheezing. , 2004, Pediatrics.

[46]  A. Kaditis,et al.  Anti‐inflammatory pharmacotherapy for wheezing in preschool children , 2007, Pediatric pulmonology.

[47]  Amanda J Lee,et al.  Short-course montelukast for intermittent asthma in children: a randomized controlled trial. , 2007, American journal of respiratory and critical care medicine.

[48]  T. Guilbert Identifying and managing the infant and toddler at risk for asthma. , 2010, The Journal of allergy and clinical immunology.

[49]  D. Vilozni,et al.  The effect of montelukast on bronchial hyperreactivity in preschool children. , 2007, Chest.

[50]  E. Baraldi,et al.  Bronchopulmonary dysplasia: definitions and long-term respiratory outcome. , 2009, Early human development.

[51]  M. Schatz,et al.  Daily or intermittent budesonide in preschool children with recurrent wheezing. , 2011, The New England journal of medicine.

[52]  W. Morgan,et al.  Asthma and wheezing in the first six years of life. The Group Health Medical Associates. , 1995, The New England journal of medicine.

[53]  C. Sorkness,et al.  Classifying asthma severity in children: Is measuring lung function helpful? , 2002 .

[54]  A. Biggeri,et al.  Risk Factors for Early, Persistent, and Late-onset Wheezing in Young Children , 1999 .

[55]  H. Bisgaard,et al.  Response of preschool children with asthma symptoms to fluticasone propionate. , 2001, The Journal of allergy and clinical immunology.

[56]  S. Szefler,et al.  Longitudinal growth in infants and young children treated with budesonide inhalation suspension for persistent asthma. , 2000, The Journal of allergy and clinical immunology.

[57]  D. Strachan,et al.  Associations of wheezing phenotypes in the first 6 years of life with atopy, lung function and airway responsiveness in mid-childhood , 2008, Thorax.

[58]  A. Goldsobel Lansoprazole for Children With Poorly Controlled Asthma: A Randomized Controlled Trial , 2012, Pediatrics.

[59]  P. Sly,et al.  The transient value of classifying preschool wheeze into episodic viral wheeze and multiple trigger wheeze , 2009, Acta paediatrica.

[60]  H. Bisgaard,et al.  Safety and tolerability of montelukast in placebo‐controlled pediatric studies and their open‐label extensions , 2009, Pediatric pulmonology.

[61]  C. Sorkness,et al.  Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing. , 2008, The Journal of allergy and clinical immunology.

[62]  B. Chipps Long-term Inhaled Corticosteroids in Preschool Children at High Risk for Asthma , 2007, Pediatrics.

[63]  Bert Brunekreef,et al.  Predicting the long-term prognosis of children with symptoms suggestive of asthma at preschool age. , 2009, The Journal of allergy and clinical immunology.

[64]  J. Castro‐Rodriguez,et al.  Efficacy of Inhaled Corticosteroids in Infants and Preschoolers With Recurrent Wheezing and Asthma: A Systematic Review With Meta-analysis , 2009, Pediatrics.

[65]  A. Biggeri,et al.  Risk factors for early, persistent, and late-onset wheezing in young children. SIDRIA Collaborative Group. , 1999, American journal of respiratory and critical care medicine.

[66]  P. Brand,et al.  Ciclesonide in wheezy preschool children with a positive asthma predictive index or atopy. , 2011, Respiratory medicine.

[67]  Varinder Singh,et al.  Diagnostic modalities for gastro-esophageal reflux in infantile wheezers. , 2011, Journal of tropical pediatrics.

[68]  J. Castro‐Rodriguez,et al.  A clinical index to define risk of asthma in young children with recurrent wheezing. , 2000, American journal of respiratory and critical care medicine.

[69]  Alfred O. Berg,et al.  Clinical Guidelines And Primary Care Guidelines For The Diagnosis And Management Of Asthma , 2012 .

[70]  L. Bacharier,et al.  Severe intermittent wheezing in preschool children: a distinct phenotype. , 2007, The Journal of allergy and clinical immunology.

[71]  Wei Wu,et al.  Efficacy and safety of inhaled fluticasone propionate chlorofluorocarbon in 2- to 4-year-old patients with asthma: results of a double-blind, placebo-controlled study. , 2006, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[72]  S. Harding Gastroesophageal reflux and asthma: insight into the association. , 1999, The Journal of allergy and clinical immunology.

[73]  A. Moeller,et al.  Effects of montelukast on subjective and objective outcome measures in preschool asthmatic children , 2008, Pediatric pulmonology.

[74]  Even Lea,et al.  Diagnostic evaluation of foreign body aspiration in children: a prospective study , 2005 .

[75]  A. Woodcock,et al.  Secondary prevention of asthma by the use of Inhaled Fluticasone propionate in Wheezy INfants (IFWIN): double-blind, randomised, controlled study , 2006, The Lancet.

[76]  C. Crim,et al.  Efficacy and safety of fluticasone propionate hydrofluoroalkane inhalation aerosol in pre-school-age children with asthma: a randomized, double-blind, placebo-controlled study. , 2006, The Journal of pediatrics.

[77]  J. de Blic,et al.  The use of imaging techniques for assessing severe childhood asthma. , 2007, The Journal of allergy and clinical immunology.

[78]  Urs Frey,et al.  Validation of the Asthma Predictive Index and comparison with simpler clinical prediction rules. , 2011, The Journal of allergy and clinical immunology.